US Patent Issued to Dragonfly Therapeutics on Feb. 4 for "Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use" (Massachusetts, New Hampshire Inventors)

ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,215,157, issued on Feb. 4, was assigned to Dragonfly Therapeutics Inc. (Waltham, Mass.).

"Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use" was invented by Gregory P. Chang (Medford, Mass.), Ann F. Cheung (Lincoln, Mass.), Asya Grinberg (Lexington, Mass.), Dhruv Kam Sethi (Belmont, Mass.), William Haney (Wayland, Mass.), Bianka Prinz (Lebanon, N.H.), Bradley M. Lunde (Lebanon, N.H.), Ronnie Wei (Weston, Mass.), Daniel Fallon (Winchester, Mass.) and Steven O'Neil (Wayland, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Multi-specific binding proteins that bind to and kill human cancer cells expressing CD33 (Siglec-...